Deborah Knobelman - Chief Financial Officer, Head of Corporate Development at Senti Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer, Head of Corporate Development
Issuer Symbol
SNTI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Deborah Knobelman since 12 Mar 2025

Holdings reported by Deborah Knobelman for Senti Biosciences, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 131,000 $572,470 $4.37 01 Feb 2024 Direct
Stock Option (Right to Buy) 152,000 01 Feb 2024 Direct Common Stock

Transactions reported by Deborah Knobelman for Senti Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.